Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06079554

Microbiota and Metabolomics of Intestinal Type of Gastric Cancer

Microbiota and Metabolomics of Intestinal Type of Gastric Cancer in the Context of Atrophic Gastritis

Status
Recruiting
Phase
Study type
Observational
Enrollment
32 (estimated)
Sponsor
Jilin University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Compare with the gastric cavity without cancerous transformation in atrophic gastritis, analyze the microbiota and metabolomics changes in intestinal type of gastric cancer under the background of atrophic gastritis, and explore the relevant mechanisms.

Detailed description

This study adopts a prospective cohort study. The expected recruitment time for all participants is 6 months, and all cases are cases who would receive magnifying endoscopy examination. The extent of atrophy and the presence of early gastric cancer are determined under magnifying endoscopy. Cases are chose into the gastric cancer group and atrophic gastritis group in a 1:1 ratio. There are 16 cases of intestinal type of gastric cancer under the background of atrophic gastritis, and 16 cases of atrophic gastritis without gastric cancer matched according to gender, age, and degree of gastric atrophy, totaling 32 cases. Analyze the characteristics of early gastric cancer under endoscopy, investigate the changes in microbiota and metabolomics of intestinal type of gastric cancer under the background of atrophic gastritis, and explore the relevant mechanisms.

Conditions

Timeline

Start date
2024-03-31
Primary completion
2024-04-28
Completion
2025-08-30
First posted
2023-10-12
Last updated
2024-04-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06079554. Inclusion in this directory is not an endorsement.